GEHCV GE HEALTHCARE TECHNOLOGIES INC

GE HealthCare Announces Advanced Imaging Innovations for OEC 3D C-arm to Help Improve Precision Care in Practice of Interventional Pulmonology

GE HealthCare (Nasdaq: GEHC) announces additional clinical applications now available as part of the OEC 3D mobile CBCT C-arm portfolio to help enable precise and efficient imaging during endoscopic bronchoscopy procedures in the practice of interventional pulmonology.

Complex pulmonary and thoracic procedures require precise intraoperative imaging systems. To diagnose and biopsy a suspected lesion or region of interest in the lungs, physicians need to visualize and confirm the precise location of nodules and tools, yet often the position of a nodule can differ from pre-operative CT images because of the differences in respiratory patterns, patient positioning, and other factors, resulting in CT to body divergence, at time of the procedure.

GE HealthCare’s OEC 3D intraoperative mobile CBCT continues to demonstrate imaging excellence and versatility for every day procedures ranging from neuro-spine and orthopedic trauma to interventional procedures, such as bronchoscopy.

Today’s announcement brings the following additions to the OEC 3D C-arm to help improve visualization of airways in the lungs during bronchoscopy procedures:

OEC 3D Lung Suite: The OEC 3D enables clinicians to visualize both 2D and 3D images of the lung using a single mobile C-arm. For advanced imaging during endoscopy procedures, the OEC 3D Lung Suite includes:

  • Augmented Fluoroscopy overlay of 3D points of interest on live fluoroscopy images.
  • Adjustable motorized 3D scan to accommodate patient or equipment positions during a spin.

OEC Open: During bronchoscopy procedures, clinicians may use navigation or robotic assistance, in addition to advanced imaging, to reach the region of interest during the interventional procedure. To help enable this workflow, OEC 3D C-arms provide an OEC Open interface for automatically transferring 3D volumetric data post reconstruction to verified navigation and robotic systems.

A recent addition to the OEC Open offering is a verified interface with the Intuitive Ion® Endoluminal Robotic Bronchoscopy System (OS 1 v5.1.0 and later). This interface enables users to automatically transfer OEC 3D mobile CBCT images upon reconstruction to the Ion System to then update target locations for clinician catheter adjustments during the procedure.

GE HealthCare continues to expand OEC Open interfaces for a variety of clinical procedures as an agnostic OEC Open ecosystem for OEC 3D users. Today, OEC Open is verified with eight, third-party systems spanning robotics, navigation, and augmented reality vision.

“With Intuitive’s Ion Robotic Bronchoscopy System now verified to interface with GE HealthCare’s OEC 3D through the OEC Open interface, I believe we can now reach and diagnose almost any nodule in the lung ,” shares Dr. Dominique Pepper, Medical Director of Bronchoscopy and Respiratory Care, Providence Swedish South Puget Sound.1 “This is a game-changer for clinicians - this can help us confidently and accurately provide answers when we see a suspicious area of interest.”

“As we continue to build out our OEC ecosystem, GE HealthCare is excited about the addition of the Intuitive Ion robotic system to our OEC Open interface,” shares Christian O’Connor – Global General Manager for Surgery at GE HealthCare. “This interface provides interventional pulmonologists using the OEC 3D C-arm a seamless experience during minimally invasive, robotic-assisted bronchoscopy procedures. Furthermore, this collaboration also signifies our continued commitment to enabling surgeons access to the latest technologies to support them in providing exceptional patient care."

These latest additions build on the company’s continuous innovation of the OEC C-arm portfolio to support clinicians in their efforts to help improve the diagnosis, treatment, and overall outcomes of their patients.

More about OEC 3D: First introduced in 2021, the OEC 3D mobile CBCT C-arm provides precise 3D and 2D imaging every day in a broad variety of procedures. During bronchoscopy procedures, clinicians can leverage CBCT visualization features, such as Lung Preset, to help optimize viewing of airway structures and Augmented Fluoroscopy with Lung Suite to help confirm tool-in-lesion during a procedure. While delivering exceptional image quality, the OEC 3D also enables seamless transition from 3D to 2D imaging through one versatile mobile CBCT imaging C-arm with an intuitive user interface and workflow to help further optimize space in the bronchoscopy suite.

Learn more at .

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits.

Follow us on ,, , , and for the latest news, or visit our website for more information.

____________________________

1
Paid Consultant: Dr. Dominique Pepper is a paid consultant for GE HealthCare. The statements by Dr. Dominique Pepper described here are based on his own opinions and on results that were achieved in his unique setting. Since there is no “typical” hospital and many variables exist, i.e. hospital size, case mix, etc. there can be no guarantee that other customers will achieve the same results.

EN
22/11/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on GE HEALTHCARE TECHNOLOGIES INC

Moody's Ratings assigns Baa2 rating to GE Healthcare's sr. notes; stab...

Moody's Ratings (Moody's) assigned a Baa2 rating to GE HealthCare Technologies Inc.'s ("GE HealthCare") proposed offering of senior unsecured notes. There are no changes to GE HealthCare's existing ratings including the Baa2 issuer rating, Baa2 senior unsecured notes ratings and (P)Baa2 senior unsec...

 PRESS RELEASE

GE HealthCare launches AI-driven, patient-friendly Invenia ABUS Premiu...

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) announced the launch of Invenia™ Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound offering advanced artificial intelligence (AI) and innovative features to drive faster*, reproducible supplemental screening and streamline exam readings on patients with dense breasts. Approximately 71% of cancers occur in dense breasts.1 According to studies across the U.S. and Europe, 40% of women2 and 70% of Asian women3 have dense breast tissue, making them four to six times more likely to receive a breast cancer diagnosis.4 Early d...

 PRESS RELEASE

GE HealthCare and NVIDIA reimagine diagnostic imaging with autonomous ...

SAN JOSE, Calif.--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced a collaboration with NVIDIA at GTC 2025, expanding the existing relationship between the two companies to focus on pioneering innovation in autonomous imaging, beginning with autonomous X-ray technologies and autonomous applications within ultrasound. GE HealthCare has been at the forefront of medical technology innovation with a series of “firsts” that date back more than a century, starting with the invention of its X-ray tube, followed by several others including the first handheld ultrasound, first 3D obstetr...

 PRESS RELEASE

GE HealthCare expands invasive cardiology solutions portfolio with Alt...

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced the launch of the AltiX AI.i edition of Mac-Lab™, CardioLab™ and ComboLab™. The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and supporting even the most complex electrophysiology (EP) procedures. These latest editions offer new features that can streamline workflow and enhance interoperability, while upholding strong cybersecurity standards. Cardiovascular disease (CVD) has nearly doubled over the past three decades, affecting more than 500 ...

 PRESS RELEASE

GE HealthCare Advances Its Cloud Strategy by Unveiling the Genesis Por...

LAS VEGAS--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced its new Genesis solutions, a portfolio of cloud enterprise imaging software-as-a-service (SaaS) solutions. Four features will be offered when commercially released – edge, storage, vendor neutral archive and data migration.i These cloud solutions, are designed to help enhance healthcare organizations’ efficiency and precision, streamline workflows, and optimize the use of capital and IT resources. The growing volume and complexity of patient cases are putting increasing pressure on hospitals’ IT systems, driving the ne...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch